Comparative Effects of A2 Platinum Stage 1 Infant Formula on Infant Digestion and Comfort

NCT04733937 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2024-10-18

No results posted yet for this study

Summary

This trial is a single-blind, randomized, controlled, parallel-designed trial to compare the effects of a2 Platinum® stage 1 infant formula versus conventional, A1 and A2 β-casein-containing stage 1 infant formula versus breastfeeding on crying, tolerance, gut health, and immune function.

Conditions

  • Healthy Infants

Interventions

OTHER

a2 Platinum® stage 1 infant formula

Upon randomization (if not included in the breastfed group), each participant will be provided with up to 105 days' supply of the standardized formula and up to 28 days' supply of the allocated formula. Participants and study investigators will conduct the trial via a pre-determined randomization schedule.

OTHER

Conventional, A1 and A2 β-casein containing stage 1 infant formula

Upon randomization (if not included in the breastfed group), each participant will be provided with up to 105 days' supply of the standardized formula and up to 28 days' supply of the allocated formula. Participants and study investigators will conduct the trial via a pre-determined randomization schedule.

Sponsors & Collaborators

  • Shanghai First Maternity and Infant Hospital

    collaborator OTHER
  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    collaborator OTHER
  • Edanz Group Japan Ltd

    collaborator UNKNOWN
  • Women & Children's Health Care Hospital of Linyi, China

    collaborator UNKNOWN
  • Beijing Esmile Technology Co. Ltd.

    collaborator UNKNOWN
  • Nanjing Maternity and Child Health Care Hospital

    collaborator OTHER
  • First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

    collaborator OTHER
  • Second Hospital of Jilin University

    collaborator OTHER
  • a2 Milk Company Ltd.

    lead INDUSTRY

Principal Investigators

  • Jiangqin Liu, MD · Shanghai First Maternity and Infant Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
0 Days
Max Age
76 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-07
Primary Completion
2022-04-16
Completion
2022-04-16

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04733937 on ClinicalTrials.gov